User login
CLINICAL UPDATEBest Practices in Injecting Evolence: A Physician's Perspective
Best Practices in Injecting Evolence: A Physician's Perspective
A supplement to Skin & Allergy News. This supplement was supported by Ortho Dermatologics.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Technique
• Results
• Discussion
Faculty/Faculty Disclosures
J. Matthew Knight, MD, FAAD, MD
Knight Dermatology Institute
Orlando, FL, USA
Dr. Knight is a stockholder of Johnson & Johnson.
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was supported by Ortho Dermatologics.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Technique
• Results
• Discussion
Faculty/Faculty Disclosures
J. Matthew Knight, MD, FAAD, MD
Knight Dermatology Institute
Orlando, FL, USA
Dr. Knight is a stockholder of Johnson & Johnson.
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was supported by Ortho Dermatologics.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Technique
• Results
• Discussion
Faculty/Faculty Disclosures
J. Matthew Knight, MD, FAAD, MD
Knight Dermatology Institute
Orlando, FL, USA
Dr. Knight is a stockholder of Johnson & Johnson.
Copyright © 2009 by Elsevier Inc.
Best Practices in Injecting Evolence: A Physician's Perspective
Best Practices in Injecting Evolence: A Physician's Perspective
BEST PRACTICES IN:Treating Rosacea: Current Insights
Treating Rosacea: Current Insights
A supplement to Skin & Allergy News. This supplement was funded by Galderma.
Topics
• Is it Rosacea?
• Managing Rosacea: Target Potential Triggers
• Treatment Options for Rosacea
• Newer Topical Formulations
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures
Richard Odom, MD
Chair
Professor, Clinical Dermatology
University of California
San Francisco School of Medicine
San Francisco, California
Advisory committee for Johnson & Johnson.
Terry Arnold, MA, PA-C
Advanced Practice Consultants, LLC
Tulsa, Oklahoma
Speaker for Medicis; advisory board of Novartis, Warner-Chilcott; advisory board/speaker for Abbott Laboratories, Astellas, Collagenex; advisory board, speaker and consultant for Amgen, Coria Labs, Ranbaxy.
Stephen Brunton, MD
Adjunct Clinical Professor
Department of Family Medicine
University of North Carolina
Chapel Hill
Chapel Hill, North Carolina
Nothing to disclose.
Mary Knudtson, DNSc, NP
Professor, Family Medicine
Director of Family Nurse Practitioner Program
University of California, Irvine
Irvine, California
Speaker's bureau for Proctor & Gamble; consultant for sanofi aventis, Galderma.
John E. Wolf, Jr., MD, MA
Professor and Chairman
Department of Dermatology
Baylor College of Medicine
Houston, Texas
Consultant, speaker, and on the advisory board for Stiefel, PharmaDerm, Galderma, Medicis, Novartis, Warner-Chilcott, consultant for QLT and Peplin; speaker for Stiefel, sanofi-aventis (Dermik).
Copyright © 2008 Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was funded by Galderma.
Topics
• Is it Rosacea?
• Managing Rosacea: Target Potential Triggers
• Treatment Options for Rosacea
• Newer Topical Formulations
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures
Richard Odom, MD
Chair
Professor, Clinical Dermatology
University of California
San Francisco School of Medicine
San Francisco, California
Advisory committee for Johnson & Johnson.
Terry Arnold, MA, PA-C
Advanced Practice Consultants, LLC
Tulsa, Oklahoma
Speaker for Medicis; advisory board of Novartis, Warner-Chilcott; advisory board/speaker for Abbott Laboratories, Astellas, Collagenex; advisory board, speaker and consultant for Amgen, Coria Labs, Ranbaxy.
Stephen Brunton, MD
Adjunct Clinical Professor
Department of Family Medicine
University of North Carolina
Chapel Hill
Chapel Hill, North Carolina
Nothing to disclose.
Mary Knudtson, DNSc, NP
Professor, Family Medicine
Director of Family Nurse Practitioner Program
University of California, Irvine
Irvine, California
Speaker's bureau for Proctor & Gamble; consultant for sanofi aventis, Galderma.
John E. Wolf, Jr., MD, MA
Professor and Chairman
Department of Dermatology
Baylor College of Medicine
Houston, Texas
Consultant, speaker, and on the advisory board for Stiefel, PharmaDerm, Galderma, Medicis, Novartis, Warner-Chilcott, consultant for QLT and Peplin; speaker for Stiefel, sanofi-aventis (Dermik).
Copyright © 2008 Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was funded by Galderma.
Topics
• Is it Rosacea?
• Managing Rosacea: Target Potential Triggers
• Treatment Options for Rosacea
• Newer Topical Formulations
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures
Richard Odom, MD
Chair
Professor, Clinical Dermatology
University of California
San Francisco School of Medicine
San Francisco, California
Advisory committee for Johnson & Johnson.
Terry Arnold, MA, PA-C
Advanced Practice Consultants, LLC
Tulsa, Oklahoma
Speaker for Medicis; advisory board of Novartis, Warner-Chilcott; advisory board/speaker for Abbott Laboratories, Astellas, Collagenex; advisory board, speaker and consultant for Amgen, Coria Labs, Ranbaxy.
Stephen Brunton, MD
Adjunct Clinical Professor
Department of Family Medicine
University of North Carolina
Chapel Hill
Chapel Hill, North Carolina
Nothing to disclose.
Mary Knudtson, DNSc, NP
Professor, Family Medicine
Director of Family Nurse Practitioner Program
University of California, Irvine
Irvine, California
Speaker's bureau for Proctor & Gamble; consultant for sanofi aventis, Galderma.
John E. Wolf, Jr., MD, MA
Professor and Chairman
Department of Dermatology
Baylor College of Medicine
Houston, Texas
Consultant, speaker, and on the advisory board for Stiefel, PharmaDerm, Galderma, Medicis, Novartis, Warner-Chilcott, consultant for QLT and Peplin; speaker for Stiefel, sanofi-aventis (Dermik).
Copyright © 2008 Elsevier Inc.
Treating Rosacea: Current Insights
Treating Rosacea: Current Insights
Roundup on Cosmetic Dermatology 2009
A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 33rdHawaii Dermatology SeminarTMand the Cosmetic Dermatology Seminar 2009TM.
• Topic Highlights
• Guest Editors
To view the supplement, click the image above.
Topic Highlights
• Update on Laser Resurfacing, Fillers, Botulinum Toxine
• Managing Fat and Cellulite: Current State of the Field
• Avoiding Dermal Filler Pitfalls Begins With a Mirror
• Single Laser Tx Reduced Perioral Wrinkles
• Fractional Laser Therapy Found Effective for Hands
Guest Editors
David J. Goldberg, M.D., J.D.
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery
Specialists of New York/New Jersey
New York, N.Y.
Dr Goldberg has nothing to disclose.
Christopher B. Zachary, M.B.B.S., F.R.C.P.
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and
Laser Center
University of California at Irvine
Dr Zachary has nothing to disclose.
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 33rdHawaii Dermatology SeminarTMand the Cosmetic Dermatology Seminar 2009TM.
• Topic Highlights
• Guest Editors
To view the supplement, click the image above.
Topic Highlights
• Update on Laser Resurfacing, Fillers, Botulinum Toxine
• Managing Fat and Cellulite: Current State of the Field
• Avoiding Dermal Filler Pitfalls Begins With a Mirror
• Single Laser Tx Reduced Perioral Wrinkles
• Fractional Laser Therapy Found Effective for Hands
Guest Editors
David J. Goldberg, M.D., J.D.
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery
Specialists of New York/New Jersey
New York, N.Y.
Dr Goldberg has nothing to disclose.
Christopher B. Zachary, M.B.B.S., F.R.C.P.
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and
Laser Center
University of California at Irvine
Dr Zachary has nothing to disclose.
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News.
This supplement was produced in affiliation with the 33rdHawaii Dermatology SeminarTMand the Cosmetic Dermatology Seminar 2009TM.
• Topic Highlights
• Guest Editors
To view the supplement, click the image above.
Topic Highlights
• Update on Laser Resurfacing, Fillers, Botulinum Toxine
• Managing Fat and Cellulite: Current State of the Field
• Avoiding Dermal Filler Pitfalls Begins With a Mirror
• Single Laser Tx Reduced Perioral Wrinkles
• Fractional Laser Therapy Found Effective for Hands
Guest Editors
David J. Goldberg, M.D., J.D.
Clinical Professor of Dermatology
Director, Laser Research and Mohs Surgery
Mount Sinai School of Medicine
Adjunct Professor of Law
Fordham Law School
New York, N.Y.
Director, Skin Laser & Surgery
Specialists of New York/New Jersey
New York, N.Y.
Dr Goldberg has nothing to disclose.
Christopher B. Zachary, M.B.B.S., F.R.C.P.
Chair and Clinical Professor
Department of Dermatology
Co-Director, Dermatologic Surgery and
Laser Center
University of California at Irvine
Dr Zachary has nothing to disclose.
Copyright © 2009 by Elsevier Inc.
BEST PRACTICES IN: Newer Topical Retinoid Therapies for the Treatment of Acne
A supplement to Skin & Allergy News and funded by Galderma.
• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary
FACULTY
Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine
Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania
Copyright © 2008 Elsevier Inc.
A supplement to Skin & Allergy News and funded by Galderma.
• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary
FACULTY
Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine
Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania
Copyright © 2008 Elsevier Inc.
A supplement to Skin & Allergy News and funded by Galderma.
• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary
FACULTY
Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine
Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania
Copyright © 2008 Elsevier Inc.
CALCITRIOL OINTMENT: A New Option for Topical Psoriasis Therapy
A supplement to Skin & Allergy News. This supplement was supported by Galderma.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Topical Vitamin D3: A Mainstay in Psoriasis Care
• Calcitriol 3 ug/g Ointment: A Unique Option for Psoriasis Treatment
• Calcitriol Ointment Long-Term Study: Safety and Efficacy for Up to 52 Weeks
• Calcitriol Ointment: Use in Psoriasis Treatment Regimens
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures
Emily Becker, MD
Clinical Research Fellow
Department of Dermatology
University of California, San Francisco
Dr. Becker has nothing to disclose.
John Y.M. Koo, MD, PhD
Professor
Department of Dermatology
University of California, San Francisco
Director, UCSF Psoriasis Treatment Center
Dr. Koo is a consultant to Abbott Laboratories, Amgen, Inc., Astellas Pharma US, Inc., Galderma Laboratories, L.P., Stiefel Laboratories, Inc., Photomedix, Inc., Novartis Pharmaceuticals Corporation, and Warner-Chilcott. He has received grant/research support from Abbott, Amgen, Astellas, Galderma, Photomedix, Ranbaxy Pharmaceuticals, Inc., Teikoku Pharma USA, Inc., and Warner-Chilcott. He also served on the speaker's bureau of Abbott, Amgen, Astellas, Galderma, and Warner-Chilcott.
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was supported by Galderma.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Topical Vitamin D3: A Mainstay in Psoriasis Care
• Calcitriol 3 ug/g Ointment: A Unique Option for Psoriasis Treatment
• Calcitriol Ointment Long-Term Study: Safety and Efficacy for Up to 52 Weeks
• Calcitriol Ointment: Use in Psoriasis Treatment Regimens
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures
Emily Becker, MD
Clinical Research Fellow
Department of Dermatology
University of California, San Francisco
Dr. Becker has nothing to disclose.
John Y.M. Koo, MD, PhD
Professor
Department of Dermatology
University of California, San Francisco
Director, UCSF Psoriasis Treatment Center
Dr. Koo is a consultant to Abbott Laboratories, Amgen, Inc., Astellas Pharma US, Inc., Galderma Laboratories, L.P., Stiefel Laboratories, Inc., Photomedix, Inc., Novartis Pharmaceuticals Corporation, and Warner-Chilcott. He has received grant/research support from Abbott, Amgen, Astellas, Galderma, Photomedix, Ranbaxy Pharmaceuticals, Inc., Teikoku Pharma USA, Inc., and Warner-Chilcott. He also served on the speaker's bureau of Abbott, Amgen, Astellas, Galderma, and Warner-Chilcott.
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News. This supplement was supported by Galderma.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Topical Vitamin D3: A Mainstay in Psoriasis Care
• Calcitriol 3 ug/g Ointment: A Unique Option for Psoriasis Treatment
• Calcitriol Ointment Long-Term Study: Safety and Efficacy for Up to 52 Weeks
• Calcitriol Ointment: Use in Psoriasis Treatment Regimens
• Surgical Therapies
• Summary
Faculty/Faculty Disclosures
Emily Becker, MD
Clinical Research Fellow
Department of Dermatology
University of California, San Francisco
Dr. Becker has nothing to disclose.
John Y.M. Koo, MD, PhD
Professor
Department of Dermatology
University of California, San Francisco
Director, UCSF Psoriasis Treatment Center
Dr. Koo is a consultant to Abbott Laboratories, Amgen, Inc., Astellas Pharma US, Inc., Galderma Laboratories, L.P., Stiefel Laboratories, Inc., Photomedix, Inc., Novartis Pharmaceuticals Corporation, and Warner-Chilcott. He has received grant/research support from Abbott, Amgen, Astellas, Galderma, Photomedix, Ranbaxy Pharmaceuticals, Inc., Teikoku Pharma USA, Inc., and Warner-Chilcott. He also served on the speaker's bureau of Abbott, Amgen, Astellas, Galderma, and Warner-Chilcott.
Copyright © 2009 by Elsevier Inc.
Emerging Treatment Options for Postinflammatory Hyperpigmentation
A supplement to Skin & Allergy News. This supplement is jointly sponsored by Skin & Allergy News and the Elsevier Office of Continuing Medical Education and supported by Barrier Therapeutics. The supplement is based on a faculty interview.
To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.
FACULTY
Susan Taylor, MD
Director, The Skin of Color Center
St. Luke's-Roosevelt Hospital
Columbia University
New York, N.Y.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of Dermatologists and other clinicians.
EDUCATIONAL NEEDS
Disorders of skin pigmentation account for a substantial proportion of many dermatologists' practices. Abnormalities characterized by hyperpigmentation are especially prominent among African-Americans and other darker-skinned individuals. Postinflammatory hyperpigmentation (PIH), an acquired increase in pigmentation secondary to an inflammatory process, is one of the common pigmentation disorders among people of color. PIH poses a therapeutic challenge to the clinician, and many patients find the condition more troubling than its inflammatory precursor. PIH can have a devastating psychological impact and substantially mar an individual's self-esteem.
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
• Understand the basic pathophysiology of PIH
• State the principal types of conditions that result in PIH
• Appreciate the impact of PIH and its effects on people of color
• Appreciate the impact of PIH and its effects on people of color
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of ContinuingMedical Education (EOCME) and Skin & Allergy News. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CREDIT DESIGNATION
The EOCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Term of Approval: October 2007 - October 31, 2008.
*Full faculty disclosures available online.
A supplement to Skin & Allergy News. This supplement is jointly sponsored by Skin & Allergy News and the Elsevier Office of Continuing Medical Education and supported by Barrier Therapeutics. The supplement is based on a faculty interview.
To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.
FACULTY
Susan Taylor, MD
Director, The Skin of Color Center
St. Luke's-Roosevelt Hospital
Columbia University
New York, N.Y.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of Dermatologists and other clinicians.
EDUCATIONAL NEEDS
Disorders of skin pigmentation account for a substantial proportion of many dermatologists' practices. Abnormalities characterized by hyperpigmentation are especially prominent among African-Americans and other darker-skinned individuals. Postinflammatory hyperpigmentation (PIH), an acquired increase in pigmentation secondary to an inflammatory process, is one of the common pigmentation disorders among people of color. PIH poses a therapeutic challenge to the clinician, and many patients find the condition more troubling than its inflammatory precursor. PIH can have a devastating psychological impact and substantially mar an individual's self-esteem.
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
• Understand the basic pathophysiology of PIH
• State the principal types of conditions that result in PIH
• Appreciate the impact of PIH and its effects on people of color
• Appreciate the impact of PIH and its effects on people of color
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of ContinuingMedical Education (EOCME) and Skin & Allergy News. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CREDIT DESIGNATION
The EOCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Term of Approval: October 2007 - October 31, 2008.
*Full faculty disclosures available online.
A supplement to Skin & Allergy News. This supplement is jointly sponsored by Skin & Allergy News and the Elsevier Office of Continuing Medical Education and supported by Barrier Therapeutics. The supplement is based on a faculty interview.
To view the supplement, click the image above. To take the CME Posttest, download and print out the CME Posttest PDF file, and follow the test instructions.
FACULTY
Susan Taylor, MD
Director, The Skin of Color Center
St. Luke's-Roosevelt Hospital
Columbia University
New York, N.Y.
TARGET AUDIENCE
This activity has been designed to meet the educational needs of Dermatologists and other clinicians.
EDUCATIONAL NEEDS
Disorders of skin pigmentation account for a substantial proportion of many dermatologists' practices. Abnormalities characterized by hyperpigmentation are especially prominent among African-Americans and other darker-skinned individuals. Postinflammatory hyperpigmentation (PIH), an acquired increase in pigmentation secondary to an inflammatory process, is one of the common pigmentation disorders among people of color. PIH poses a therapeutic challenge to the clinician, and many patients find the condition more troubling than its inflammatory precursor. PIH can have a devastating psychological impact and substantially mar an individual's self-esteem.
LEARNING OBJECTIVES
Upon completion of this educational activity, participants should be able to:
• Understand the basic pathophysiology of PIH
• State the principal types of conditions that result in PIH
• Appreciate the impact of PIH and its effects on people of color
• Appreciate the impact of PIH and its effects on people of color
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Elsevier Office of ContinuingMedical Education (EOCME) and Skin & Allergy News. The EOCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.
CREDIT DESIGNATION
The EOCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Term of Approval: October 2007 - October 31, 2008.
*Full faculty disclosures available online.
CLINICAL UPDATE: Safety and Efficacy of Evolence: A Novel Injectable Dermal Filler
A supplement to Skin & Allergy News and supported by OrthoNeutrogena.
• Faculty/Faculty Disclosures
• Topics
To view the supplement, click the image above.
Faculty/Faculty Disclosures
Pearl E. Grimes, Jr., MD, Director
Vitiligo and Pigmentation Institute of Southern California
Los Angeles, Calif.
Dr. Grimes has received grant support from Johnson & Johnson.
Kenneth R. Beer, MD, FAAD
Palm Beach Esthetic Dermatology and Laser Center
West Palm Beach, Fla.
Dr.Beer has nothing to disclose.
Z. Paul Lorenc, MD, FACS
Lorenc Aesthetic Plastic Surgery
New York, N.Y.
Dr. Lorenc has nothing to disclose.
Topics
• Composition and Properties
• Clinical Data
• Summary
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News and supported by OrthoNeutrogena.
• Faculty/Faculty Disclosures
• Topics
To view the supplement, click the image above.
Faculty/Faculty Disclosures
Pearl E. Grimes, Jr., MD, Director
Vitiligo and Pigmentation Institute of Southern California
Los Angeles, Calif.
Dr. Grimes has received grant support from Johnson & Johnson.
Kenneth R. Beer, MD, FAAD
Palm Beach Esthetic Dermatology and Laser Center
West Palm Beach, Fla.
Dr.Beer has nothing to disclose.
Z. Paul Lorenc, MD, FACS
Lorenc Aesthetic Plastic Surgery
New York, N.Y.
Dr. Lorenc has nothing to disclose.
Topics
• Composition and Properties
• Clinical Data
• Summary
Copyright © 2009 by Elsevier Inc.
A supplement to Skin & Allergy News and supported by OrthoNeutrogena.
• Faculty/Faculty Disclosures
• Topics
To view the supplement, click the image above.
Faculty/Faculty Disclosures
Pearl E. Grimes, Jr., MD, Director
Vitiligo and Pigmentation Institute of Southern California
Los Angeles, Calif.
Dr. Grimes has received grant support from Johnson & Johnson.
Kenneth R. Beer, MD, FAAD
Palm Beach Esthetic Dermatology and Laser Center
West Palm Beach, Fla.
Dr.Beer has nothing to disclose.
Z. Paul Lorenc, MD, FACS
Lorenc Aesthetic Plastic Surgery
New York, N.Y.
Dr. Lorenc has nothing to disclose.
Topics
• Composition and Properties
• Clinical Data
• Summary
Copyright © 2009 by Elsevier Inc.
Exploring the Role of Genetics In Atopic Dermatitis
A supplement to Skin and Allergy News.
This Journal Scan Supplement to Skin and Allergy News was sponsored by Promius Pharma.
• Summary of Key Articles
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Summary of Key Articles
• Exploring the Role of Genetics in Atopic Dermatitis
• Filaggrin Variants and Susceptibility to Atopic Dermatitis
• Impact of Prevalent FLG Mutations on Atopic Dermatitis Risk
• EpiCeram
A supplement to Skin and Allergy News.
This Journal Scan Supplement to Skin and Allergy News was sponsored by Promius Pharma.
• Summary of Key Articles
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Summary of Key Articles
• Exploring the Role of Genetics in Atopic Dermatitis
• Filaggrin Variants and Susceptibility to Atopic Dermatitis
• Impact of Prevalent FLG Mutations on Atopic Dermatitis Risk
• EpiCeram
A supplement to Skin and Allergy News.
This Journal Scan Supplement to Skin and Allergy News was sponsored by Promius Pharma.
• Summary of Key Articles
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Summary of Key Articles
• Exploring the Role of Genetics in Atopic Dermatitis
• Filaggrin Variants and Susceptibility to Atopic Dermatitis
• Impact of Prevalent FLG Mutations on Atopic Dermatitis Risk
• EpiCeram
Botanical Ingredients: Powered by Nature, Proven by ScienceTOPIC HIGHLIGHTS OF A CLINICAL ROUNDTABLE
TOPIC HIGHLIGHTS OF A CLINICAL ROUNDTABLE
A supplement to Skin & Allergy News.
This educational supplement was supported by Johnson & Johnson Consumer Products Company.
• Topics
• Guest Editors/Disclosures
To view the supplement, click the image above.
Topics
• Abstract
• Introduction: The Emerging Role of Natural Ingredients in Dermatology
• Active Naturals: Ancient Medicine Enters the Scientific Age
• From the Environment to the Laboratory
• Establishing Benefits in Humans
• Bringing Useful Products to Patients
• Active Naturals Have a Key Role in Atopic Dermatitis
• Natural Ingredients and Atopic Dermatitis
• Natural Approaches to Management of Photoaging
• The Aging Process
• Botanical Agents in Skin Protection
• Pigmentation Disorders in Skin of Color: The Role of Natural Substances
• Properties and Benefits of Soy
• Licorice
• Kojic Acid
Guest Editors/Disclosures
Leslie S. Baumann, MD
Director-University of Miami
Cosmetic Medicine and Research Institute
Professor of Dermatology
University of Miami
Miami, Fla.
Dr Baumann is a speaker and a consultant for Johnson & Johnson Consumer Products.
Cherie M. Ditre, MD
Director
Skin Enhancement Center and Cosmetic Dermatology
University of Pennsylvania School of Medicine
Berwyn, Pennsylvania
Dr. Ditre is a consultant for Johnson & Johnson Consumer Products.
Joseph Fowler, Jr., MD
Clinical Professor of Dermatology
University of Louisville
Louisville, Kentucky
Dr. Fowler has received funding for clinical research from and is a consultant for Johnson & Johnson Consumer Products.
Marta I. Rendon, MD
Associate Clinical Professor
University of Miami and Florida Atlantic University
Medical Director
Dermatology & Aesthetic Center
Boca Raton, Florida
Dr. Rendon is a consultant for Johnson & Johnson Consumer Products.
Darrell Rigel, MD
Clinical Professor
Department of Dermatology
New York University Medical Center
New York, New York
Dr. Rigel has received funding for clinical grants from and is a consultant for Neutrogena Corporation.
Nanette Silverberg, MD
Director
Pediatric and Adolescent Dermatology
St. Luke's-Roosevelt Hospital Center
New York, New York
Dr. Silverberg has received funding for clinical research from Novartis and is a consultant for Johnson & Johnson Consumer Products.
Susan Taylor, MD
Director
Society Hill Dermatology
Philadelphia, Pennsylvania
Dr. Taylor has received funding for clinical research from and is a consultant for Johnson & Johnson Consumer Products.
Heather Woolery-Lloyd, MD
Director of Ethnic Skin Care
University of Miami
Cosmetic Medicine and Research Institute
Assistant Professor of Dermatology
University of Miami
Miami, FL
Dr. Woolery-Lloyd is a consultant for Johnson & Johnson Consumer Products.
Copyright © 2008 Elsevier Inc.
A supplement to Skin & Allergy News.
This educational supplement was supported by Johnson & Johnson Consumer Products Company.
• Topics
• Guest Editors/Disclosures
To view the supplement, click the image above.
Topics
• Abstract
• Introduction: The Emerging Role of Natural Ingredients in Dermatology
• Active Naturals: Ancient Medicine Enters the Scientific Age
• From the Environment to the Laboratory
• Establishing Benefits in Humans
• Bringing Useful Products to Patients
• Active Naturals Have a Key Role in Atopic Dermatitis
• Natural Ingredients and Atopic Dermatitis
• Natural Approaches to Management of Photoaging
• The Aging Process
• Botanical Agents in Skin Protection
• Pigmentation Disorders in Skin of Color: The Role of Natural Substances
• Properties and Benefits of Soy
• Licorice
• Kojic Acid
Guest Editors/Disclosures
Leslie S. Baumann, MD
Director-University of Miami
Cosmetic Medicine and Research Institute
Professor of Dermatology
University of Miami
Miami, Fla.
Dr Baumann is a speaker and a consultant for Johnson & Johnson Consumer Products.
Cherie M. Ditre, MD
Director
Skin Enhancement Center and Cosmetic Dermatology
University of Pennsylvania School of Medicine
Berwyn, Pennsylvania
Dr. Ditre is a consultant for Johnson & Johnson Consumer Products.
Joseph Fowler, Jr., MD
Clinical Professor of Dermatology
University of Louisville
Louisville, Kentucky
Dr. Fowler has received funding for clinical research from and is a consultant for Johnson & Johnson Consumer Products.
Marta I. Rendon, MD
Associate Clinical Professor
University of Miami and Florida Atlantic University
Medical Director
Dermatology & Aesthetic Center
Boca Raton, Florida
Dr. Rendon is a consultant for Johnson & Johnson Consumer Products.
Darrell Rigel, MD
Clinical Professor
Department of Dermatology
New York University Medical Center
New York, New York
Dr. Rigel has received funding for clinical grants from and is a consultant for Neutrogena Corporation.
Nanette Silverberg, MD
Director
Pediatric and Adolescent Dermatology
St. Luke's-Roosevelt Hospital Center
New York, New York
Dr. Silverberg has received funding for clinical research from Novartis and is a consultant for Johnson & Johnson Consumer Products.
Susan Taylor, MD
Director
Society Hill Dermatology
Philadelphia, Pennsylvania
Dr. Taylor has received funding for clinical research from and is a consultant for Johnson & Johnson Consumer Products.
Heather Woolery-Lloyd, MD
Director of Ethnic Skin Care
University of Miami
Cosmetic Medicine and Research Institute
Assistant Professor of Dermatology
University of Miami
Miami, FL
Dr. Woolery-Lloyd is a consultant for Johnson & Johnson Consumer Products.
Copyright © 2008 Elsevier Inc.
A supplement to Skin & Allergy News.
This educational supplement was supported by Johnson & Johnson Consumer Products Company.
• Topics
• Guest Editors/Disclosures
To view the supplement, click the image above.
Topics
• Abstract
• Introduction: The Emerging Role of Natural Ingredients in Dermatology
• Active Naturals: Ancient Medicine Enters the Scientific Age
• From the Environment to the Laboratory
• Establishing Benefits in Humans
• Bringing Useful Products to Patients
• Active Naturals Have a Key Role in Atopic Dermatitis
• Natural Ingredients and Atopic Dermatitis
• Natural Approaches to Management of Photoaging
• The Aging Process
• Botanical Agents in Skin Protection
• Pigmentation Disorders in Skin of Color: The Role of Natural Substances
• Properties and Benefits of Soy
• Licorice
• Kojic Acid
Guest Editors/Disclosures
Leslie S. Baumann, MD
Director-University of Miami
Cosmetic Medicine and Research Institute
Professor of Dermatology
University of Miami
Miami, Fla.
Dr Baumann is a speaker and a consultant for Johnson & Johnson Consumer Products.
Cherie M. Ditre, MD
Director
Skin Enhancement Center and Cosmetic Dermatology
University of Pennsylvania School of Medicine
Berwyn, Pennsylvania
Dr. Ditre is a consultant for Johnson & Johnson Consumer Products.
Joseph Fowler, Jr., MD
Clinical Professor of Dermatology
University of Louisville
Louisville, Kentucky
Dr. Fowler has received funding for clinical research from and is a consultant for Johnson & Johnson Consumer Products.
Marta I. Rendon, MD
Associate Clinical Professor
University of Miami and Florida Atlantic University
Medical Director
Dermatology & Aesthetic Center
Boca Raton, Florida
Dr. Rendon is a consultant for Johnson & Johnson Consumer Products.
Darrell Rigel, MD
Clinical Professor
Department of Dermatology
New York University Medical Center
New York, New York
Dr. Rigel has received funding for clinical grants from and is a consultant for Neutrogena Corporation.
Nanette Silverberg, MD
Director
Pediatric and Adolescent Dermatology
St. Luke's-Roosevelt Hospital Center
New York, New York
Dr. Silverberg has received funding for clinical research from Novartis and is a consultant for Johnson & Johnson Consumer Products.
Susan Taylor, MD
Director
Society Hill Dermatology
Philadelphia, Pennsylvania
Dr. Taylor has received funding for clinical research from and is a consultant for Johnson & Johnson Consumer Products.
Heather Woolery-Lloyd, MD
Director of Ethnic Skin Care
University of Miami
Cosmetic Medicine and Research Institute
Assistant Professor of Dermatology
University of Miami
Miami, FL
Dr. Woolery-Lloyd is a consultant for Johnson & Johnson Consumer Products.
Copyright © 2008 Elsevier Inc.
TOPIC HIGHLIGHTS OF A CLINICAL ROUNDTABLE
TOPIC HIGHLIGHTS OF A CLINICAL ROUNDTABLE
Cosmeceutical Critique Compendium - A Review of Natural Ingredients.
A supplement to Skin & Allergy News.
This supplement was supported by Johnson and Johnson Consumer Companies, Inc.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Avenanthramides Continue the Evolution of Dermatologic Use of Oat Products
• Feverfew for Treatment of Sensitive Skin and
• Inflammatory Skin Conditions
• Mushrooms: Part I
• Mushrooms: Part II
• Coffea arabica and CoffeeBerry Extract
• Boswellia
• Soy and Its Isoflavones
• Licorice: Part II
• Arnica Montana L.
• Ginseng
Faculty/Faculty Disclosures
Leslie S. Baumann, MD
Professor of Dermatology
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, Fla.
Dr Baumann has received funding for clinical research from Avon Products, Inc., Allergan, Inc., Galderma Laboratories, L.P., Medicis Pharmaceuticals Corporation, and Unilever PLC. She is also a consultant for Philosophy, Proctor & Gamble, ReVance Therapeutics, Inc., Stiefel Laboratories, Inc., and Vicky.
Dr Baumann is on the editorial advisory board of SKIN & ALLERGY NEWS.
Jessica Wu, MD
Clinical Instructor of Dermatology
University of Southern California
Los Angeles, Calif.
Dr Wu is a consultant for Johnson & Johnson Consumer Products.
Copyright © 2008 by Elsevier Inc.
A supplement to Skin & Allergy News.
This supplement was supported by Johnson and Johnson Consumer Companies, Inc.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Avenanthramides Continue the Evolution of Dermatologic Use of Oat Products
• Feverfew for Treatment of Sensitive Skin and
• Inflammatory Skin Conditions
• Mushrooms: Part I
• Mushrooms: Part II
• Coffea arabica and CoffeeBerry Extract
• Boswellia
• Soy and Its Isoflavones
• Licorice: Part II
• Arnica Montana L.
• Ginseng
Faculty/Faculty Disclosures
Leslie S. Baumann, MD
Professor of Dermatology
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, Fla.
Dr Baumann has received funding for clinical research from Avon Products, Inc., Allergan, Inc., Galderma Laboratories, L.P., Medicis Pharmaceuticals Corporation, and Unilever PLC. She is also a consultant for Philosophy, Proctor & Gamble, ReVance Therapeutics, Inc., Stiefel Laboratories, Inc., and Vicky.
Dr Baumann is on the editorial advisory board of SKIN & ALLERGY NEWS.
Jessica Wu, MD
Clinical Instructor of Dermatology
University of Southern California
Los Angeles, Calif.
Dr Wu is a consultant for Johnson & Johnson Consumer Products.
Copyright © 2008 by Elsevier Inc.
A supplement to Skin & Allergy News.
This supplement was supported by Johnson and Johnson Consumer Companies, Inc.
• Topic Highlights
• Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topic Highlights
• Avenanthramides Continue the Evolution of Dermatologic Use of Oat Products
• Feverfew for Treatment of Sensitive Skin and
• Inflammatory Skin Conditions
• Mushrooms: Part I
• Mushrooms: Part II
• Coffea arabica and CoffeeBerry Extract
• Boswellia
• Soy and Its Isoflavones
• Licorice: Part II
• Arnica Montana L.
• Ginseng
Faculty/Faculty Disclosures
Leslie S. Baumann, MD
Professor of Dermatology
Chief, Division of Cosmetic Dermatology
University of Miami
Miami, Fla.
Dr Baumann has received funding for clinical research from Avon Products, Inc., Allergan, Inc., Galderma Laboratories, L.P., Medicis Pharmaceuticals Corporation, and Unilever PLC. She is also a consultant for Philosophy, Proctor & Gamble, ReVance Therapeutics, Inc., Stiefel Laboratories, Inc., and Vicky.
Dr Baumann is on the editorial advisory board of SKIN & ALLERGY NEWS.
Jessica Wu, MD
Clinical Instructor of Dermatology
University of Southern California
Los Angeles, Calif.
Dr Wu is a consultant for Johnson & Johnson Consumer Products.
Copyright © 2008 by Elsevier Inc.
